Abivax Not Rushing Deals as It Awaits Crucial Trial Results
French biotech company Abivax is choosing patience over urgency. Despite growing takeover speculation, the company is holding off on major
Eli Lilly Makes History: How a Weight-Loss Shot Pushed a Drugmaker to the Trillion-Dollar Club
For the first time in history, a health-care company has stepped into a territory once reserved almost entirely for the
Novartis Just Dropped $12 Billion on a Biotech Firm — This Could Change Medicine Forever
Novartis Makes a Jaw-Dropping $12 Billion Move Swiss pharmaceutical giant Novartis shocked the biotech world by agreeing to acquire U.S.-based